KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Depreciation and Depletion (2018 - 2019)

ClearPoint Neuro recorded quarterly Depreciation and Depletion of $35710.0 in Q3 2019, up 2.15% quarter-over-quarter from $34960.0 in Q2 2019, and up 38.48% year-over-year from $25788.0 in Q3 2018.

ClearPoint Neuro's Depreciation and Depletion history runs 2 years deep, the most recent figure standing at $35710.0 for Q3 2019.

  • In Q3 2019, Depreciation and Depletion rose 38.48% year-over-year to $35710.0; the TTM figure through Sep 2019 stood at $131098.0 (changed N/A YoY), while the FY2025 annual figure was $400000.0, up 100.0% from the prior year.
  • Depreciation and Depletion came in at $35710.0 for Q3 2019 at ClearPoint Neuro, up from $34960.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $35710.0 in Q3 2019 to a low of $23795.0 in Q2 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 381.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 120.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 308.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 29.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 78.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 ClearPoint Neuro 375.84 Mn 340.24 Mn 7.76 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2019 35,710.00
Sep 30, 2019 35,710.00
Jun 30, 2019 34,960.00
Jun 30, 2019 34,960.00
Mar 31, 2019 34,640.00
Mar 31, 2019 34,640.00
Sep 30, 2018 25,788.00
Sep 30, 2018 25,788.00
Jun 30, 2018 23,795.00
Jun 30, 2018 23,795.00
Mar 31, 2018 31,623.00
Mar 31, 2018 31,623.00